Smita Bhatia, M.D., MPH, a distinguished pediatric oncologist with a strong interest in cancer outcomes, will be join the School of Medicine to tackle the health challenges cancer survivors face during and after treatment.
HudsonAlpha and the UAB Cancer Center establish joint cancer research consortium focusing on cancer genomics, with multiple hires expected.
Christopher Willey, M.D., Ph.D., receives a crucial ACS research grant to further his novel work on the MARCKS protein in relation to brain cancer.
Becker’s Hospital Review has named the UAB Comprehensive Cancer Center as one of the “100 Hospitals and Health Systems With Great Oncology Programs.”
Scarinci’s work in the community is one reason for her appointment, and her goals will include promoting and fostering relationships in business, education and other areas.
Isabel Scarinci, M.Ph., Ph.D., associate professor in UAB Division of Preventive Medicine, has been appointed to the newly created position of associate director of globalization and cancer at the UAB Comprehensive Cancer Center.
Pediatric cancer researcher Gregory Friedman, M.D., receives $40,000 grant to fight brain cancer in children.
Researchers at the University of Alabama at Birmingham have identified a strategy that highly aggressive brain tumor cells use to fuel their relentless expansion.
The Journal of Biological Chemistry recognizes UAB scientists’ paper on exosomes, particles that change the behavior of cells, while the research team examines shutting down tumor growth.
The UAB Comprehensive Cancer Center has been selected as a lead academic site and received a prestigious NCI grant that will open up clinical trials across a nationwide network and expand treatment options for patients.